R&G PharmaStudies Co (SZSE:301333) Receivables Turnover : 1.79 (As of Mar. 2024)

R&G PharmaStudies Co Receivables Turnover Chart

R&G PharmaStudies Co Annual Data
	Trend	Dec13	Dec14	Dec15	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Receivables Turnover		Get a 7-Day Free Trial					8.10	12.85	10.76	8.70	8.86

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															2.17	2.14	1.61	2.18	1.79

Competitive Comparison of R&G PharmaStudies Co's Receivables Turnover

For the Biotechnology subindustry, R&G PharmaStudies Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's Receivables Turnover falls into.

R&G PharmaStudies Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

R&G PharmaStudies Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

R&G PharmaStudies Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

R&G PharmaStudies Co  (SZSE:301333) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

R&G PharmaStudies Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description